Grant: Discovery Grants Program - Individual
École Polytechnique de Montréal
$41,000.00
Improving reproducibility in MRI with vendor-neutral acquisitions and transparent workflows
EF 2023-24
Résumé
Myelin is a key component of the central nervous system. The myelin sheaths insulate axons with a triple effect: allowing fast electrical conduction, protecting the axon, and providing structural support. Myelin is also relevant from a clinical perspective, given that demyelination is often observed in several neurological diseases such as multiple sclerosis Quantitative magnetic resonance imaging (qMRI) assigns units to MR images, making it possible to quantify myelin content across MRI scanners. The one thing that makes a broad clinical adoption of quantitative MRI difficult is the lack of transparency and standardization in qMRI protocols. Most qMR techniques are developed in-house and lack the proper framework to deploy on multiple scanners manufactured by different MRI vendors. To overcome this problem, we propose to develop a vendor-neutral platform that uses open-source pulse sequence development ("Spinbench"), real-time interaction with the scanner, and an open-source image analysis toolbox (qMRLab.org) that aims to bring quantitative MRI under one umbrella. Our long-term goal is to improve the accuracy and reliability of qMRI maps across vendors, in phantoms and in vivo. We will start by focusing on fundamental qMRI parameters (T1), and slowly expand to incorporate other qMRI modalities sensitive to myelin. Using this framework, we will (i) Develop a standardized pipeline for processing qMRI maps; (ii) Validate our pipeline in objects designed to mimic human tissue (phantoms); (iii) Conduct a multi-vendor MRI study of the myelin content in healthy subjects and multiple sclerosis (MS) patients, showing that the protocols are reproducible and clinically feasible in healthy and pathological nervous tissue. MS will be used as a proof of concept because its characteristics enable the comparison of different types of myelin degeneration, from focal inflammation to global neurodegeneration. By reproducing myelin measurements across vendors, we will make it possible for clinicians to use standardized tools for diagnosis, follow-up, and prognosis. Additionally, this will make it possible to remove vendor-dependent bias from artificial intelligence (AI) algorithms. Finally, we plan to generalize this platform to other pathologies and body parts, eventually building an `App store' for quantitative MRI that will be vendor-agnostic, open-source and accessible to clinicians worldwide.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2022-05308
Name nom
Stikov, Nikola
Department département
Electrical Engineering
Organization id
64
Institution établissement
École Polytechnique de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2022
Award amount
41000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1505
Committee name en
Physics
Committee name fr
Physique
Area of application code
518
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Medical equipment and apparatus
Area of application fr
Appareils et instruments médicaux
Research subject code
1901
Research subject group en
Biomedical engineering
Research subject group fr
Biomedical technology
Research subject en
Génie biomédical
Research subject fr
Technologie biomédicale
Application title
Improving reproducibility in MRI with vendor-neutral acquisitions and transparent workflows
Keyword
clinical validation; data standards; image processing; interoperability; magnetic resonance imaging (MRI); myelin imaging; open publishing; open science; reproducibility; science communication
Application summary
Myelin is a key component of the central nervous system. The myelin sheaths insulate axons with a triple effect: allowing fast electrical conduction, protecting the axon, and providing structural support. Myelin is also relevant from a clinical perspective, given that demyelination is often observed in several neurological diseases such as multiple sclerosis Quantitative magnetic resonance imaging (qMRI) assigns units to MR images, making it possible to quantify myelin content across MRI scanners. The one thing that makes a broad clinical adoption of quantitative MRI difficult is the lack of transparency and standardization in qMRI protocols. Most qMR techniques are developed in-house and lack the proper framework to deploy on multiple scanners manufactured by different MRI vendors. To overcome this problem, we propose to develop a vendor-neutral platform that uses open-source pulse sequence development ("Spinbench"), real-time interaction with the scanner, and an open-source image analysis toolbox (qMRLab.org) that aims to bring quantitative MRI under one umbrella. Our long-term goal is to improve the accuracy and reliability of qMRI maps across vendors, in phantoms and in vivo. We will start by focusing on fundamental qMRI parameters (T1), and slowly expand to incorporate other qMRI modalities sensitive to myelin. Using this framework, we will (i) Develop a standardized pipeline for processing qMRI maps; (ii) Validate our pipeline in objects designed to mimic human tissue (phantoms); (iii) Conduct a multi-vendor MRI study of the myelin content in healthy subjects and multiple sclerosis (MS) patients, showing that the protocols are reproducible and clinically feasible in healthy and pathological nervous tissue. MS will be used as a proof of concept because its characteristics enable the comparison of different types of myelin degeneration, from focal inflammation to global neurodegeneration. By reproducing myelin measurements across vendors, we will make it possible for clinicians to use standardized tools for diagnosis, follow-up, and prognosis. Additionally, this will make it possible to remove vendor-dependent bias from artificial intelligence (AI) algorithms. Finally, we plan to generalize this platform to other pathologies and body parts, eventually building an `App store' for quantitative MRI that will be vendor-agnostic, open-source and accessible to clinicians worldwide.